Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy

被引:233
作者
Abel, E. Dale [1 ,2 ]
Doenst, Torsten [3 ]
机构
[1] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA
[2] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84112 USA
[3] Univ Jena, Dept Cardiothorac Surg, D-07747 Jena, Germany
关键词
Cardiac hypertrophy; Mitochondria; Heart failure; Signal transduction; ACTIVATED PROTEIN-KINASE; LEFT-VENTRICULAR HYPERTROPHY; SYMPATHETIC-NERVOUS-SYSTEM; METABOLIC GENE-EXPRESSION; FATTY-ACID-METABOLISM; FAILING HUMAN HEART; OXIDATIVE STRESS; SKELETAL-MUSCLE; CARDIOLIPIN BIOSYNTHESIS; ENERGY-METABOLISM;
D O I
10.1093/cvr/cvr015
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Cardiac hypertrophy is a stereotypic response of the heart to increased workload. The nature of the workload increase may vary depending on the stimulus (repetitive, chronic, pressure, or volume overload). If the heart fully adapts to the new loading condition, the hypertrophic response is considered physiological. If the hypertrophic response is associated with the ultimate development of contractile dysfunction and heart failure, the response is considered pathological. Although divergent signalling mechanisms may lead to these distinct patterns of hypertrophy, there is some overlap. Given the close relationship between workload and energy demand, any form of cardiac hypertrophy will impact the energy generation by mitochondria, which are the key organelles for cellular ATP production. Significant changes in the expression of nuclear and mitochondrially encoded transcripts that impact mitochondrial function as well as altered mitochondrial proteome composition and mitochondrial energetics have been described in various forms of cardiac hypertrophy. Here, we review mitochondrial alterations in pathological and physiological hypertrophy. We suggest that mitochondrial adaptations to pathological and physiological hypertrophy are distinct, and we shall review potential mechanisms that might account for these differences.
引用
收藏
页码:234 / 242
页数:9
相关论文
共 109 条
[1]
Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance [J].
Abdul-Ghani, Muhammad A. ;
Muller, Florian L. ;
Liu, Yuhong ;
Chavez, Alberto O. ;
Balas, Bogdan ;
Zuo, Pengou ;
Chang, Zhi ;
Tripathy, Devjit ;
Jani, Rucha ;
Molina-Carrion, Marjorie ;
Monroy, Adriana ;
Folli, Franco ;
Van Remmen, Holly ;
DeFronzo, Ralph A. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (03) :E678-E685
[2]
Upregulation of Nox4 by Hypertrophic Stimuli Promotes Apoptosis and Mitochondrial Dysfunction in Cardiac Myocytes [J].
Ago, Tetsuro ;
Kuroda, Junya ;
Pain, Jayashree ;
Fu, Cexiong ;
Li, Hong ;
Sadoshima, Junichi .
CIRCULATION RESEARCH, 2010, 106 (07) :1253-U183
[3]
Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation [J].
Akki, Ashwin ;
Smith, Katie ;
Seymour, Anne-Marie L. .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2008, 311 (1-2) :215-224
[4]
Energy substrate metabolism in cardiac hypertrophy [J].
Allard, MF .
CURRENT HYPERTENSION REPORTS, 2004, 6 (06) :430-435
[5]
CONTRIBUTION OF OXIDATIVE-METABOLISM AND GLYCOLYSIS TO ATP PRODUCTION IN HYPERTROPHIED HEARTS [J].
ALLARD, MF ;
SCHONEKESS, BO ;
HENNING, SL ;
ENGLISH, DR ;
LOPASCHUK, GD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :H742-H750
[6]
AMPK and metabolic adaptation by the heart to pressure overload [J].
Allard, Michael F. ;
Parsons, Hannah L. ;
Saeedi, Ramesh ;
Wambolt, Richard B. ;
Brownsey, Roger .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (01) :H140-H148
[7]
Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1α [J].
Arany, Zoltan ;
Novikov, Mikhail ;
Chin, Sherry ;
Ma, Yanhong ;
Rosenzweig, Anthony ;
Spiegelman, Bruce M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) :10086-10091
[8]
Control of cardiac growth by histone acetylation/deacetylation [J].
Backs, J ;
Olson, EN .
CIRCULATION RESEARCH, 2006, 98 (01) :15-24
[9]
Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth [J].
Barger, PM ;
Brandt, JM ;
Leone, TC ;
Weinheimer, CJ ;
Kelly, DP .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1723-1730
[10]
Diabetic cardiomyopathy revisited [J].
Boudina, Sihem ;
Abel, E. Dale .
CIRCULATION, 2007, 115 (25) :3213-3223